When tumor grew to an average size around 50-100mm3, mice were randomized into four groups treated with pyrotinib 40 mg/kg, HDACs/mTOR inhibitor 1 10 mg/kg or combined with same dosages of vehicle. Here, MTOR is linked to neoplasm.